Loading...
The American College of Physicians (ACP) has issued a new publication on prostate cancer screening, focusing mainly on prostate-specific antigen (PSA) testing. The statement begins with a synopsis of four published guidelines — those of the U.S. Preventive Task Force, American Cancer Society, American Urologic Association, and American College of Preventive Medicine — and ends with two “Guidance Statements.” Along the way, the authors briefly review the evidence for and against screening, and list ten talking points for use in discussions between clinicians and patients.
In the first guidance statement, ACP recommends that clinicians “inform men between the age of 50 and 69 years about the limited potential benefits and substantial harms of …